Simulations Plus Azione

Simulations Plus EV/FCF

Il EV/FCF (Valore aziendale su flusso di cassa libero) di Simulations Plus (SLP) al 23 ago 2026 è 12,36. L'anno precedente, EV/FCF (Valore aziendale su flusso di cassa libero) era 17,83 — una variazione del -30,65% (inferiore).

EV/FCF

12,36

YoY

-30,65%

Ultimo aggiornamento:

EV/FCF (Valore aziendale su flusso di cassa libero) di Simulations Plus ammonta a 2026 12,36 . EV/FCF (Valore aziendale su flusso di cassa libero) di Simulations Plus ammontava a 2025 17,83 . Diminuisce del -30,65% inferiore rispetto all'anno precedente.

La storia di Simulations Plus EV/FCF

  • 3 anni

  • 10 anni

  • 25 anni

  • Max

EV/FCF
Date
EV/FCF
1 gen 2018
34,23 USD
1 gen 2019
24,39 USD
1 gen 2020
15,80 USD
1 gen 2021
8,48 USD
1 gen 2022
8,57 USD
1 gen 2023
7,52 USD
1 gen 2024
17,83 USD
1 gen 2025
12,36 USD
La storia di Simulations Plus EV/FCF
ANNOEV/FCFYoY
12,36-30,65%
17,83+137,19%
7,52-12,30%
8,57+1,08%
8,48-46,35%
15,80-35,21%
24,39-28,75%
34,23-24,58%
45,39-20,80%
57,31+41,32%
40,55-76,03%
169,18
Access this data via the Eulerpool API

Simulations Plus Analisi delle Azioni

Cosa fa Simulations Plus? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Simulations Plus azioni

EV/FCF (Valore aziendale su flusso di cassa libero) di Simulations Plus è 12,36 nel 2026.

Il EV/FCF (Valore aziendale su flusso di cassa libero) di Simulations Plus è passato da 17,83 a 12,36, con una variazione del -30,65 %. Il valore è inferiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Simulations Plus di EV/FCF (Valore aziendale su flusso di cassa libero) dal 2006, con valori annuali, grafici e analisi dettagliate.

Il rapporto EV/FCF misura il valore aziendale rispetto al flusso di cassa libero. Cattura la vera capacità di generazione di cassa di un'azienda.

Per valutare di EV/FCF (Valore aziendale su flusso di cassa libero), è essenziale confrontarlo con i competitor nello stesso settore e industria. Su Eulerpool puoi trovare confronti diretti con l'industria per EV/FCF (Valore aziendale su flusso di cassa libero).

Un 'buono' varia a seconda del settore e della fase di sviluppo dell'azienda. Su Eulerpool puoi confrontare Simulations Plus di EV/FCF (Valore aziendale su flusso di cassa libero) con i competitor del settore e la media industriale per valutare se è attraente.

Access this data via the Eulerpool API

Valutazione — Simulations Plus

Tutte le Metriche Finanziarie — Simulations Plus